Table 2.
Clinical outcomes pre- and post-FMT.
| Respondersa |
Nonrespondersa |
|||||
|---|---|---|---|---|---|---|
| Variable | n | Pre-FMT Mean ± SD | Post-FMT Mean ± SD | n | Pre-FMT Mean ± SD | Post-FMT Mean ± SD |
| HBI (one month post-FMT) | 3 | 11.3 ± 4.6 | 8.0 ± 4.4 | 7 | 6.9 ± 3.2 | 9.7 ± 4.8 |
| Stool frequency (number/day) | 3 | 6.3 ± 3.1 | 4.7 ± 1.5 | 7 | 4.3 ± 3.6 | 7.0 ± 3.4 |
| Pain (scale 0–3) | 3 | 1.7 ± 0.6 | 1.0 ± 1.0 | 7 | 1.3 ± 0.5 | 1.4 ± 1.0 |
| CRP (mg/l) | 2 | 35.0 ± 47.4 | 27.6 ± 33.7 | 7 | 6.8 ± 7.2 | 11.0 ± 12.4 |
| ESR (mm/h) | 2 | 65.5 ± 48.8 | 67.5 ± 46 | 7 | 27.7 ± 24.7 | 32.3 ± 36.7 |
| Fecal calprotectin (mcg/g) | 2 | 560 ± 411 | 624 ± 755 | 5 | 313 ± 289 | 868 ± 776 |
| SES CD score | 3 | 9.3 ± 10.1 | 9.3 ± 9.5 | 3 | 7.7 ± 4.8 | 7.7 ± 3.8 |
CD: Crohn disease; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; FMT: fecal microbiota transplantation; HBI: Harvey-Bradshaw index; SES: Simple Endoscopic Score.
Clinical outcomes of responders pre- and post-FMT and nonresponders pre- and post-FMT. Data are presented as mean ± SD.
a
Values compared by Wilcoxon signed-rank test.
All p values >0.05.